Diabetic foot ulcer prevention that works.

The Podimetrics SmartMat helps prevent diabetic foot complications before they start with clinically-proven technologies and customizable, human-to-human support.

Download our new Adherence White Paper!

Together, we can help you set new standards in preventive care for diabetic foot complications.

Diabetic foot ulcer prevention in just 20 seconds per day.

With the Podimetrics SmartMat™, you can empower your patients to protect their mobility in a new, easy and effective way.

DFUs are costly, common, and preventable.

Learn more about how Podimetrics helps solve this problem.

Working in conjunction with payors and providers, Podimetrics provides a simple, in-home touchpoint to help stop diabetic foot complications.

Patients with advanced diabetes step on their in-home SmartMat™ for just 20 seconds a day.

Podimetrics does the rest:

Monitor foot temperature over time

Alert to early signs of inflammation

Rapidly respond to help reduce inflammation before complications start

Support patients and their providers, every step of the way

Reduced Complications and Amputations

In a peer reviewed study, involving a year long foot ulcer recurrence prevention program at four outpatient centers, Podimetrics reduced:

0%
All diabetic amputations reduced by 71%1
0%
Severe DFUs reduced by 91%1
0%
All DFUs reduced by 46%1

Patient Experience and Adherence

In two different studies:

0%
75% Of patients remained
engaged at one year2
0%
88% of patients rated the
SmartMat “easy to use”3

Cost Savings and ROI

Podimetrics calculates up to $13,000 in annual cost savings per patient4

3.6X – 5.2X

3.6X - 5.2X expected return on investment (ROI)1

$9,800 – 14,000

$9,800 - 14,000 expected annual cost savings per member5

The SmartMat™ Works.

In a peer reviewed study, involving a year long foot ulcer recurrence prevention program at four outpatient centers, Podimetrics reduced:

0%
All-cause inpatient admissions:
52% relative risk reduction1
0%
Emergency department visits 40% relative risk reduction1
0%
All-cause outpatient admissions 26% relative risk reduction1
2
Two fewer podiatry outpatient visits per participant year during the treatment phase1

† Net difference was observed despite 1.6 additional podiatry outpatient visits per-participant year resulting from inflammation detected by the study device.

Ready to learn more? 

Schedule a 15 minute discovery call now to learn how Podimetrics could help your organization.

What's new at Podimetrics?

All News

1. American Diabetes Association. The Cost of Diabetes.